The SMA program structure Our Weight Management Program is designed to address safety gaps in unsupervised GLP-1 use while making the medications accessible at affordable prices
Important notes: Do not aspirate (pull back on the plunger) before injecting this is not necessary for subcutaneous injections and is not possible with the pen device
Avoid sun exposure, sweating, picking skin, exfoliating products, and retinoids until healing is complete
Identify outliers (suspiciously cheap suggesting poor quality or too expensive without justifying quality difference)
The Endocrine Society 2023 guidelines recommend long-term or indefinite anti-obesity pharmacotherapy for patients whose weight-related comorbidities improve on treatment and would predictably relapse off it [3]
How GLP-1 medications can change your poop GLP-1 medications affect everyones digestive systems differently, leading to a wide range of poop-related problems or none at all